A downtrend has been apparent in Definitive Healthcare Corp. (DH) lately. While the stock has lost 5.8% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about ...

| --- | --- | --- | --- | --- | |-------|------------------|---------------|-------|-------| | | | | | | | | | | | | | | | | | | | | Third quarter | 2023 earnings | | | | | presentation | | | | | | November 2, 2023 | | | | Cautionary statement regarding forward-looking statements 2 Forward-looking statements in this press release are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by t ...

Definitive Healthcare Corp. (NASDAQ:DH) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Matt Ruderman - Chief Legal Officer Robert Musslewhite - CEO Jason Krantz - Founder and Executive Chairman Rick Booth - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley David Grossman - Stifel Glen Santangelo - Jefferies Matt Shea - Needham & Company Joe Vruwink - Baird Allen Lutz - Bank of America Johnathan McCary - Raymond James Jared Haase - William Blair George Hill ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 For the transition period from to or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) | Delaware | | 86-3988281 | | --- | ...

Definitive Healthcare Corp. (NASDAQ:DH) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Matt Ruderman - Chief Legal Officer Robert Musslewhite - Chief Executive Officer Jason Krantz - Founder and Executive Chairman Rick Booth - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Matt Shea - Needham & Company Brian Peterson - Raymond James Allen Lutz - Bank of America David Grossman - Stifel Jonathan Yong - Credit Suisse George Hill - Deutsch ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) | Delaware | | 86-3988281 | | --- | --- ...

Definitive Healthcare Corp. (NASDAQ:DH) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Matt Ruderman – Chief Legal Officer Robert Musslewhite – Chief Executive Officer Jason Krantz – Founder and Executive Chairman Rick Booth – Chief Financial Officer Conference Call Participants Jared Haase – William Blair Matt Shea – Needham & Co. Craig Hettenbach – Morgan Stanley Joe Vruwink – Baird David Grossman – Stifel Allen Lutz – Bank of America Johnathan McCary – Raymond James Jonathan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other jur ...

Business Overview - As of December 31, 2022, Definitive Healthcare had over 3,000 active paid subscriptions to its platform[19]. - Definitive Healthcare's total addressable market is estimated to exceed $10 billion, targeting over 100,000 companies[31]. - The platform utilizes thousands of data sources and billions of data points, enhanced by AI and machine learning algorithms, to provide comprehensive healthcare commercial intelligence[23]. Workforce and Culture - The company employs 974 individuals, with 30% working fully remote, and has a workforce distribution of 517 in sales and marketing, 361 in product development, and 96 in general and administrative roles[34]. - The company has implemented unlimited paid time off and expanded parental leave for U.S.-based employees in 2022[42]. - The management team has a strong track record of exceptional financial performance and building a positive workplace culture[27]. - The company has been recognized as a Top Place to Work by The Boston Globe for six consecutive years[35]. Financial Performance - As of December 31, 2022, the company had cash and cash equivalents of $146.9 million and short-term investments of $184.9 million[340]. - The total principal balance outstanding on the 2021 Term Loan was $266.4 million as of December 31, 2022[341]. - A hypothetical 1.0% increase or decrease in the interest rate associated with borrowings under the 2021 Credit Agreement would result in an approximately $2.7 million impact to interest expense on an annual basis[342]. - The company does not believe inflation has had a material effect on its business, financial condition, or results of operations[344]. Risk Management - The company manages credit risk by concentrating cash deposits and short-term investments with high-quality financial institutions[345]. Growth Strategy - Definitive Healthcare's go-to-market strategy generates over 10,000 inbound Marketing Qualified Leads (MQLs) annually[30]. - The company aims to drive growth through acquiring new customers, expanding existing relationships, and making selective strategic acquisitions[27]. Intellectual Property - Definitive Healthcare has not pursued any patents as of December 31, 2022, but protects its intellectual property through contracts and confidentiality agreements[46]. International Presence - The company has one foreign entity established in Sweden and one in India, with functional currencies being the Swedish Krona and the Indian Rupee, respectively[343].

Definitive Healthcare Corp. (NASDAQ:DH) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Matt Ruderman - General Counsel Robert Musslewhite - CEO Jason Krantz - Chairman Rick Booth - CFO Conference Call Participants David Grossman - Stifel Craig Hettenbach - Morgan Stanley Jacob Staffel - Goldman Sachs Matt Shea - Needham Ryan Shanahan - Canaccord Genuity Glen Santangelo - Jefferies Brian Peterson - Raymond James Anne Samuel - JPMorgan Allen Lutz - Bank of America Operator ...